Tacey Viegas
Corporate Officer/Principal bei BIOCRYST PHARMACEUTICALS, INC.
Vermögen: 538 685 $ am 30.04.2024
Profil
Tacey Viegas is currently the Executive Director of Product Development at BioCryst Pharmaceuticals, Inc. He also holds positions as the Chief Operating Officer at Serina Therapeutics (AL), Inc. and as the Secretary and Chief Operating Officer at Serina Therapeutics, Inc. Previously, he served as the Director of Product Development at MDV Technologies, Inc. from 1989 to 1994.
Dr. Viegas holds a graduate and doctorate degree from the University of Mississippi and an undergraduate degree from the University of Bangalore.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
2,34% | 26.03.2024 | 58 610 ( 2,34% ) | 538 685 $ | 30.04.2024 |
Aktive Positionen von Tacey Viegas
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Serina Therapeutics, Inc.
 Serina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Serina Therapeutics, Inc. is a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL. | Geschäftsführer | 01.11.2006 |
Ehemalige bekannte Positionen von Tacey Viegas
| Unternehmen | Position | Ende |
|---|---|---|
MDV Technologies, Inc.
 MDV Technologies, Inc. Medical SpecialtiesHealth Technology Part of Alliance Pharmaceutical Corp., MDV Technologies, Inc. develops and makes medical products. The company is based in Dearborn, MI. MDV Technologies was acquired by Alliance Pharmaceutical Corp. on November 14, 1996 for $35.50 million. | Corporate Officer/Principal | 02.01.1994 |
Ausbildung von Tacey Viegas
| University of Mississippi | Doctorate Degree |
| University of Bangalore | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
MDV Technologies, Inc.
MDV Technologies, Inc. Medical SpecialtiesHealth Technology Part of Alliance Pharmaceutical Corp., MDV Technologies, Inc. develops and makes medical products. The company is based in Dearborn, MI. MDV Technologies was acquired by Alliance Pharmaceutical Corp. on November 14, 1996 for $35.50 million. | Health Technology |
Serina Therapeutics, Inc.
Serina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Serina Therapeutics, Inc. is a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL. | Commercial Services |
